Cargando…

Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece

BACKGROUND: Polymorphisms of the vitamin D receptor (VDR) gene have been linked to both multiple sclerosis (MS) and osteoporosis. We examined the frequency of the Taq-I and Bsm-I polymorphisms of the vitamin D receptor (VDR) gene in 69 patients with MS and 81 age and sex-matched healthy individuals....

Descripción completa

Detalles Bibliográficos
Autores principales: Sioka, Chrissa, Papakonstantinou, Stylianos, Markoula, Sofia, Gkartziou, Foteini, Georgiou, Athanasia, Georgiou, Ioannis, Pelidou, Sygliti-Henrietta, Kyritsis, Athanassios P, Fotopoulos, Andreas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097159/
https://www.ncbi.nlm.nih.gov/pubmed/21545713
http://dx.doi.org/10.1186/1477-5751-10-3
_version_ 1782203791993470976
author Sioka, Chrissa
Papakonstantinou, Stylianos
Markoula, Sofia
Gkartziou, Foteini
Georgiou, Athanasia
Georgiou, Ioannis
Pelidou, Sygliti-Henrietta
Kyritsis, Athanassios P
Fotopoulos, Andreas
author_facet Sioka, Chrissa
Papakonstantinou, Stylianos
Markoula, Sofia
Gkartziou, Foteini
Georgiou, Athanasia
Georgiou, Ioannis
Pelidou, Sygliti-Henrietta
Kyritsis, Athanassios P
Fotopoulos, Andreas
author_sort Sioka, Chrissa
collection PubMed
description BACKGROUND: Polymorphisms of the vitamin D receptor (VDR) gene have been linked to both multiple sclerosis (MS) and osteoporosis. We examined the frequency of the Taq-I and Bsm-I polymorphisms of the vitamin D receptor (VDR) gene in 69 patients with MS and 81 age and sex-matched healthy individuals. Genotyping of Taq-I (rs731236) and Bsm-I (rs1544410) was performed using TaqMan(® )SNP Genotyping Assay. All patients and controls had determination of body mass index (BMI), bone mineral density (BMD) and smoking history. RESULTS: The mean age of patients was 39 ± 10.5 years compared to 38.7 ± 10.7 years of the controls (p = 0.86), the BMI was 24.8 ± 4.2 kg/m(2 )compared to 25.7 ± 4.8 kg/m(2 )of the controls (p = 0.23), the BMD in the lumbar spine 0.981 ± 0.15 compared to 1.025 ± 013 of the controls (p = 0.06) and the total hip BMD was 0.875 ± 0.14 compared to 0.969 ± 0.12 of the controls (p < 0.001). There were no differences of the Taq-I (TT, CT, CC) and Bsm-I genotypes (GG, GA, AA) and allelic frequencies between MS and control individuals. Multivariate analysis also failed to show any association of the Taq-I and Bsm-I polymorphisms and MS or sex, BMI, BMD and smoking history. CONCLUSIONS: This study suggests that the Taq-I and Bsm-I polymorphisms of the VDR gene are not associated with MS risk, BMI or BMD in the Greek population studied.
format Text
id pubmed-3097159
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30971592011-05-19 Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece Sioka, Chrissa Papakonstantinou, Stylianos Markoula, Sofia Gkartziou, Foteini Georgiou, Athanasia Georgiou, Ioannis Pelidou, Sygliti-Henrietta Kyritsis, Athanassios P Fotopoulos, Andreas J Negat Results Biomed Research BACKGROUND: Polymorphisms of the vitamin D receptor (VDR) gene have been linked to both multiple sclerosis (MS) and osteoporosis. We examined the frequency of the Taq-I and Bsm-I polymorphisms of the vitamin D receptor (VDR) gene in 69 patients with MS and 81 age and sex-matched healthy individuals. Genotyping of Taq-I (rs731236) and Bsm-I (rs1544410) was performed using TaqMan(® )SNP Genotyping Assay. All patients and controls had determination of body mass index (BMI), bone mineral density (BMD) and smoking history. RESULTS: The mean age of patients was 39 ± 10.5 years compared to 38.7 ± 10.7 years of the controls (p = 0.86), the BMI was 24.8 ± 4.2 kg/m(2 )compared to 25.7 ± 4.8 kg/m(2 )of the controls (p = 0.23), the BMD in the lumbar spine 0.981 ± 0.15 compared to 1.025 ± 013 of the controls (p = 0.06) and the total hip BMD was 0.875 ± 0.14 compared to 0.969 ± 0.12 of the controls (p < 0.001). There were no differences of the Taq-I (TT, CT, CC) and Bsm-I genotypes (GG, GA, AA) and allelic frequencies between MS and control individuals. Multivariate analysis also failed to show any association of the Taq-I and Bsm-I polymorphisms and MS or sex, BMI, BMD and smoking history. CONCLUSIONS: This study suggests that the Taq-I and Bsm-I polymorphisms of the VDR gene are not associated with MS risk, BMI or BMD in the Greek population studied. BioMed Central 2011-05-05 /pmc/articles/PMC3097159/ /pubmed/21545713 http://dx.doi.org/10.1186/1477-5751-10-3 Text en Copyright ©2011 Sioka et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Sioka, Chrissa
Papakonstantinou, Stylianos
Markoula, Sofia
Gkartziou, Foteini
Georgiou, Athanasia
Georgiou, Ioannis
Pelidou, Sygliti-Henrietta
Kyritsis, Athanassios P
Fotopoulos, Andreas
Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece
title Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece
title_full Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece
title_fullStr Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece
title_full_unstemmed Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece
title_short Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece
title_sort vitamin d receptor gene polymorphisms in multiple sclerosis patients in northwest greece
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097159/
https://www.ncbi.nlm.nih.gov/pubmed/21545713
http://dx.doi.org/10.1186/1477-5751-10-3
work_keys_str_mv AT siokachrissa vitamindreceptorgenepolymorphismsinmultiplesclerosispatientsinnorthwestgreece
AT papakonstantinoustylianos vitamindreceptorgenepolymorphismsinmultiplesclerosispatientsinnorthwestgreece
AT markoulasofia vitamindreceptorgenepolymorphismsinmultiplesclerosispatientsinnorthwestgreece
AT gkartzioufoteini vitamindreceptorgenepolymorphismsinmultiplesclerosispatientsinnorthwestgreece
AT georgiouathanasia vitamindreceptorgenepolymorphismsinmultiplesclerosispatientsinnorthwestgreece
AT georgiouioannis vitamindreceptorgenepolymorphismsinmultiplesclerosispatientsinnorthwestgreece
AT pelidousyglitihenrietta vitamindreceptorgenepolymorphismsinmultiplesclerosispatientsinnorthwestgreece
AT kyritsisathanassiosp vitamindreceptorgenepolymorphismsinmultiplesclerosispatientsinnorthwestgreece
AT fotopoulosandreas vitamindreceptorgenepolymorphismsinmultiplesclerosispatientsinnorthwestgreece